• Skip to main navigation
  • Skip to main content
  • Skip to Footer
  • Navigate Novartis
    • Patients
    • Healthcare Professionals
    • Media
    • Investors
    • Partners
    • ESG
    • Job Seekers
    • Clinical Trials
  • Coronavirus
  • Global
    • Novartis site directory
Novartis logo: a global healthcare company
  • Our Company
    • Our Leadership
      • Board of Directors
      • Executive Committee of Novartis
    • Our Approach
      • Strategy
      • Corporate Responsibility
      • Diversity & Inclusion
      • Partnering
      • People and Culture
    • Our Business
      • Global Product Portfolio
      • Innovative Medicines
      • Novartis Pharmaceuticals
      • Novartis Gene Therapies
      • Novartis Oncology
      • Sandoz
    • Media
      • Newsroom
      • News Archive
      • Multimedia Resources
      • Subscribe to Updates
    • Investors
      • Event Calendar
      • Financial Data
      • Share Data & Analysis
      • Shareholder Information
      • Environmental, Social & Governance
  • Our Focus
    • Disease Areas
      • Cancer
      • Cardiovascular, Renal and Metabolic Medicine
      • Immunology & Dermatology
      • Ophthalmology
      • Neuroscience
      • Respiratory
    • Platforms and Technology
      • Data and Digital
      • Cell & Gene Therapy
    • Novartis Stories
      • Discovery
      • From Our Labs
      • Access to Healthcare
      • Patient Perspectives
      • People and Culture
      • Live Magazine
  • Our Impact
    • Building Trust with Society
      • Corporate Responsibility
      • Ethical Standards
      • Access
      • Environmental Sustainability
    • Global Health
      • Malaria
      • Sickle Cell Disease
      • Chagas disease
      • Leprosy
      • Novartis Foundation
    • ESG Performance and Reporting
      • Materiality Assessment
      • Environmental, Social and Governance
      • Transparency and Disclosures
      • Positions on Key Topics
      • Statements on Key Issues
  • Our Science
    • Research & Early Development
      • Novartis Institutes for BioMedical Research
      • Research Disease Areas
      • Postdoc Program
      • Open Source Science
    • Drug Development at Novartis
      • Novartis Pipeline
      • Clinical Trials
      • Translational Medicine
      • Global Product Portfolio
    • Science Stories
      • Discovery
      • From Our Labs
  • Careers
    • Your Career
      • Global Career Search
      • Teams and Skills
      • Gene Therapies Careers
    • Working at Novartis
      • Diversity & Inclusion
      • People and Culture
      • Corporate Responsibility
    • Career Programs
      • Our Career Programs
      • Students and Scholars
      • Novartis Quantitative Sciences Hackathon
Search
Dr. Chang As Xinh updates a patient's medical records at his surgery in Mù Cang Chải, Vietnam.
  • TwitterTweet
  • FacebookShare
  • Share
    • Twitter
    • Facebook
    • LinkedIn
    • Email
    • Whatsapp
  • Jump to Comments
Stories/Access to Healthcare

Bringing modern medicine to rural Vietnam

Efforts are underway to reinforce health education and healthcare delivery in rural Vietnam to combat a rise in chronic diseases such as diabetes, hypertension and respiratory ailments.

Nov 25, 2015

Dr. Chang As Xinh, 37, is one of just 15 doctors who deliver medical care to more than 40,000 people living in Mù Cang Chải, a rural district of Yen Bai province in northeast Vietnam. It’s a very poor part of the country rich in natural beauty and inhabited mostly by H’mong people, an ethnic minority. 

Dr. Xinh grew up in Mù Cang Chải, so he understands local traditions and speaks the H’mong dialect, enabling him to communicate easily with patients, understand their ailments and treat them. The H’mong have numerous health problems, some linked to traditional beliefs and lifestyles. For instance, it is still common here to use open fires to cook and heat houses and the indoor air pollution has led to widespread respiratory ailments.

Giang Giua Cua, 77, is typical of the patients that Dr. Xinh sees. He has Chronic Obstructive Pulmonary Disease (COPD) after many years of inhaling smoke at home. Because he is short of breath, Cua is no longer capable of trekking to the community hospital, so the doctor must come to him. 

A patient has her blood pressure checked
Access to Healthcare

Dealing with the spread of chronic disease in Africa

Respiratory illness is just one of the chronic diseases that are on the rise in Vietnam, as they are elsewhere in the world. For instance, cases of diabetes have tripled in Vietnam over the past decade, according to the World Health Organization. Hypertension is also on the increase. These and other chronic ailments, which can require ongoing treatment for years or even decades, are adding significantly to the existing burden felt by healthcare providers.

Efforts to improve public health in the region have been complicated by locals’ reliance on traditional medicines, as well as their reluctance to seek medical attention. And the need for more healthcare professionals remains acute, says Dr. Cu Hong, director of the Mù Cang Chải community hospital.

But the situation is changing. Mù Cang Chải will eventually benefit from a program begun in 2013 by the Ministry of Health to increase the number of rural doctors.  Efforts are underway to reinforce health education and healthcare delivery in rural Vietnam. One initiative is Healthy Family, or Cung Song Khoe in Vietnamese. It replicates an existing successful for-profit social venture, Arogya Parivar, developed by Novartis in India in 2007. Cung Song Khoe was launched in 2012 by Novartis in collaboration with the Vietnamese government, and involves doctors working at community health centers to raise health awareness among rural communities, and expand access to treatment and health screening. 

In Mù Cang Chải, for instance, doctors are making strides in the area of disease prevention. Community clinics run patient-education classes to inform people about the risk of developing chronic illnesses such as diabetes and hypertension. And they offer diagnostic tests, uncovering problems before they become acute. 

Such progress gives Dr. Hong hope. He believes that education will help people adopt healthier lifestyles. And he looks forward to the arrival of more medical personnel to reinforce the efforts that he and Dr. Xinh are making. 

Novartis Access 

Noncommunicable diseases (NCDs) are expected to overtake infectious diseases in low- and middle- income countries in the next two decades. Novartis Access focuses on the affordability and availability of 15 patented and generic medicines addressing four key NCDs. Test your knowledge about NCDs.

Learn more    

Tags: 
Access to Healthcare, Cancer, Chronic Illness, Living With Disease, Novartis Access, Novartis Social Business
    • TwitterTweet
    • FacebookShare
    • Share
      • Twitter
      • Facebook
      • LinkedIn
      • Email
      • Whatsapp
    • Jump to Comments
  • Print
  • Save

Novartis Stories

View all

Dr. Theophile Tuyisabe standing next to his patients smiling at him
Access to Healthcare

Meet a visionary who beat the odds to realize his vision of inclusive eye care

Access to Healthcare

Chagas disease: Breaking the silence

Sandoz in Kalwe, India ensures multidrug therapy (MTD) supply to WHO to fight leprosy
Access to Healthcare

Ensuring medicine supply to patients during COVID-19

You are here

  1. Home ›
  2. Stories ›
  3. Access healthcare

Novartis Global

  • Navigate Novartis

    • Patients & Caregivers
    • Healthcare Professionals
    • Investors
    • Media
    • Society & ESG
    • Partners
  • Contact Us

    • Global Contacts
    • Office Locations
    • For Investors
    • For Media
  • About Novartis

    • Our Company
    • Our Focus
    • Our Impact
    • Our Science
    • Our Stories
  • Our Portfolio

    • Global Product Portfolio
    • Global Clinical Pipeline
  • Careers

    • Career Search

Connect with Novartis

  • twitter
  • linkedin
  • youtube
  • facebook
  • instagram
Novartis Site Directory
© 2021 Novartis AG
  • Terms of Use
  • Privacy Policy
  • Contact Us
  • Site Map
  • Cookie Settings

This site is intended for a global audience.